Turtle Therapy on HbA1c and Self-Efficacy Levels With Type 2 Diabetes
NCT ID: NCT07298837
Last Updated: 2025-12-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
51 participants
INTERVENTIONAL
2024-07-18
2024-11-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
BASIC_SCIENCE
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Live Turtle Group
Before starting the study, a nurse who was unaware of the study details (to prevent bias) administered the "Structured Patient Information Form" and "Diabetes Medication Self-Efficacy Scale", and the "hemoglobin A1c " value measured immediately before the study began was recorded. At the end of the three-month pet therapy period, the same nurse administered the "Diabetes Medication Self-Efficacy Scale" test, and the physician recorded the "hemoglobin A1c" value result as requested. During this process, patients continued their routine Type 2 Diyabetus Mellitus treatment.
Live Turtle Therapy (Pet therapy)
The individuals were asked to take on the responsibility of caring for the turtles. The patients in this group were given one turtle and the necessary materials (aquarium, food, aquarium sand, etc.) for 12 weeks. Within this scope, patients fed the turtles twice a day, once in the morning (08:00) and once in the evening (20:00), and changed the water in the aquarium every two days with water that had been kept at room temperature beforehand. In addition, they were asked to spend 20 minutes a day with the turtle. During the twelve-week (3-month) period in which the individuals took responsibility for turtle care, the "Turtle Monitoring Form" was administered by the executor to evaluate the time spent with the turtle and the implementation of practices related to how they performed turtle care.
Video Turtle Group
Before starting the study, a nurse who was unaware of the study details (to prevent bias) administered the "Structured Patient Information Form" and "Diabetes Medication Self-Efficacy Scale", and the "hemoglobin A1c" value result measured immediately before the study began was recorded.In addition, at the end of the three-month pet therapy period, the same nurse administered the "Diabetes Medication Self-Efficacy Scale" and the physician recorded the "hemoglobin A1c" value result requested. During this process, patients continued their routine Type 2 Diyabetus Mellitus treatment.
Video Turtle Therapy (Pet therapy)
In addition, the consultant faculty member provided approximately 15 minutes of face-to-face information to patients regarding watching the turtle videos. Patients in this group were asked to watch documentaries featuring turtle videos for at least 20 minutes a day for twelve weeks. The "Turtle Viewing Form" was administered by the researcher to determine how many minutes per day the individuals watched the turtle videos.
Control Group
A nurse who was unaware of the study details prior to its commencement (to prevent bias) administered the "Structured Patient Information Form" and "Diabetes Medication Self-Efficacy Scale", and the "hemoglobin A1c" value result obtained immediately before the study began was recorded. No intervention was performed on these patients. Patients only continued their routine Type 2 Diyabetus Mellitus treatments. In addition, "Diabetes Medication Self-Efficacy Scale" was administered to patients at the end of the three-month period, and the "hemoglobin A1c" value requested by the physician was recorded.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Live Turtle Therapy (Pet therapy)
The individuals were asked to take on the responsibility of caring for the turtles. The patients in this group were given one turtle and the necessary materials (aquarium, food, aquarium sand, etc.) for 12 weeks. Within this scope, patients fed the turtles twice a day, once in the morning (08:00) and once in the evening (20:00), and changed the water in the aquarium every two days with water that had been kept at room temperature beforehand. In addition, they were asked to spend 20 minutes a day with the turtle. During the twelve-week (3-month) period in which the individuals took responsibility for turtle care, the "Turtle Monitoring Form" was administered by the executor to evaluate the time spent with the turtle and the implementation of practices related to how they performed turtle care.
Video Turtle Therapy (Pet therapy)
In addition, the consultant faculty member provided approximately 15 minutes of face-to-face information to patients regarding watching the turtle videos. Patients in this group were asked to watch documentaries featuring turtle videos for at least 20 minutes a day for twelve weeks. The "Turtle Viewing Form" was administered by the researcher to determine how many minutes per day the individuals watched the turtle videos.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Agreement to participate in the study,
* Being literate,
* Being able to communicate verbally,
* No vision, hearing, or speech impairments,
* Agreeing to adopt and care for a turtle (turtle group),
* Ownership of a smartphone, tablet, or computer (video turtle group),
* Having been diagnosed with T2DM and having been receiving DM treatment for at least 6 months,
* HbA1c \>7%.
Exclusion Criteria
* Not having T2DM,
* Having received DM treatment for less than 6 months,
* Having a psychiatric disorder diagnosed by a psychiatrist.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Gümüşhane Universıty
OTHER
Karadeniz Technical University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Hatice Demirağ, Ph.D
Assistant Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Gümüşhane University
Gümüşhane, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
RCS04072024
Identifier Type: -
Identifier Source: org_study_id